Headline 141.8% revenue jump clashes with HY23 figures the company itself cites

On the supplied prior-comparable base ($208.0m revenue, $164.0m EBITDA, –$4.0m NPAT), this produced canonical revenue growth of 141.8%, PBT growth of 340.0% and NPAT growth of 225.0%, all flagged above Annolyse's historical baseline.

The company's own release commentary, however, cites HY23 revenue of $487m, EBITDA of $342m and NPAT of $9m. Against that base, revenue and EBITDA growth would be only low single digits and NPAT would have fallen. The two anchors give materially different reads, and every above-normal income-statement classification in this briefing rests on the canonical base.

Operating cash flow rose to $243.0m from $148.0m, but cash conversion fell to 70.0% from 90.2%. Net debt/EBITDA improved to 7.46x from 11.90x. The interim dividend lifted to 19.0c from 12.5c.

Every above-normal classification on the income statement — 141.8% revenue growth, 340.0% PBT growth, 225.0% NPAT growth — depends on the supplied HY23 base. The company's own HY23 figures imply far smaller movements, so the central investor question is which base is the right anchor rather than how to interpret outsized growth.

Cash conversion fell while reported earnings rose. OCF/EBITDA dropped from 90.2% to 70.0%, still within the supplied historical range of 63.9%–90.2% but well below the prior comparable. This matters because capex stayed heavy at 46.1% of revenue and FCF pre-lease was only $11.0m — accounting earnings are not flowing through to cash as fully as a year ago.

Leverage strengthened. Net debt/EBITDA at 7.46x sits below Annolyse's historical mean of 9.63x and well under the prior 11.90x. For a regulated, capital-intensive fibre business, lower leverage expands headroom for capex and distributions, though $2.7b of gross borrowings and total liabilities up 73.6% also reflect an expanding balance sheet (total assets $6.1b, above the supplied historical range).

Annualised HY24 revenue runs at $1b versus FY23's $965m. The shape context is informative but the same comparability concern applies — if HY23 revenue was $487m as the release commentary states, the implied second-half pattern changes meaningfully.

No forward targets or guidance items are supplied in the extraction, so this briefing cannot test the result against management's stated FY24 ambitions.

On the canonical basis PBT is the cleaner operating read, but no one-offs or discontinued operations are disclosed in the supplied extraction to explain the tax-rate jump, so it remains a quality concern rather than an explained distortion.

Cash quality is mixed. OCF rose by $95m in absolute terms but conversion stepped down materially from 90.2% to 70.0%. FCF pre-lease of $11.0m sits within the supplied historical range (mean $4.4m), and the 220.0% FCF-to-NPAT ratio reflects the small reported earnings base rather than abundant cash generation. Capex at $232.0m keeps the business in a heavy-invest phase, and the 19.0c interim dividend cannot be assessed against payout-from-FCF because the canonical pack does not supply that calculation.

This briefing cannot assess the true underlying operating growth rate because the canonical prior-comparable figures and the HY23 figures cited in the company's own release commentary do not reconcile.